Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Rivian Replaces Nvidia With Its Own AI Chip as Hands-Free Driving Expands: What It Means for the R2 and RIVN Stock in 2026

Rivian Replaces Nvidia With Its Own AI Chip as Hands-Free Driving Expands: What It Means for the R2 and RIVN Stock in 2026

Dec. 19, 2025 — Rivian is making one of the boldest moves any young automaker can attempt: replacing a best‑in‑class supplier (Nvidia) with its own in‑house autonomy silicon, while simultaneously pushing hands‑free driving to far more roads for existing owners. The strategy is reshaping how the EV maker talks about its future—less “electric adventure brand,” more “AI-defined vehicle platform”—and it’s a big reason Rivian is back in the center of the autonomy conversation heading into 2026. EE Times+2Business Wire+2 On Dec. 19, Wall Street’s reaction was immediate: fresh analyst enthusiasm centered on Rivian’s R2 launch runway, autonomy monetization, and vertical
19 December 2025
······
Centrus Energy Corp (LEU) Stock Jumps on Dec. 19, 2025 as It Starts U.S. Centrifuge Manufacturing for Uranium Enrichment Expansion

Centrus Energy Corp (LEU) Stock Jumps on Dec. 19, 2025 as It Starts U.S. Centrifuge Manufacturing for Uranium Enrichment Expansion

Centrus Energy Corp. (NYSE: LEU) stock moved sharply higher on December 19, 2025 after the company announced a milestone that goes well beyond a typical corporate update: it has begun domestic centrifuge manufacturing to support commercial low-enriched uranium (LEU) enrichment at its Piketon, Ohio site—an early, concrete step in a multi-year plan to rebuild U.S.-owned enrichment capacity. Centrus Energy+1 As of 15:34 UTC on December 19, LEU stock traded around $255, up roughly 11% on the session (after opening near $235 and ranging roughly between $230 and $257 intraday). The move underscores how tightly Centrus is tied to one of
19 December 2025
····
DJT Stock News Today (Dec. 19, 2025): Trump Media’s $6 Billion TAE Fusion Deal Ignites Volatility—What It Means for Investors

DJT Stock News Today (Dec. 19, 2025): Trump Media’s $6 Billion TAE Fusion Deal Ignites Volatility—What It Means for Investors

Trump Media & Technology Group Corp. (ticker: DJT) is back at the center of the market’s attention on Friday, December 19, 2025—and not because of anything ordinary like ad revenue, user growth, or streaming subscriptions. Instead, DJT shares are moving on a headline that sounds like it escaped from a sci‑fi writer’s brainstorming session: a planned all‑stock merger valued at more than $6 billion with nuclear-fusion company TAE Technologies—a transaction that would reposition the Truth Social parent as a fusion-energy-and-media holding company. Reuters+1 As of 14:38 UTC on Dec. 19, DJT was trading around $15.26, after opening near $15.36, with
19 December 2025
··
Rocket Lab (RKLB) Stock in Focus After Space Force DiskSat Launch, JAXA Tech Demo Mission, and New $805M SDA Award

Rocket Lab (RKLB) Stock in Focus After Space Force DiskSat Launch, JAXA Tech Demo Mission, and New $805M SDA Award

Dec. 19, 2025 — Rocket Lab is ending the week at the center of both the space economy and Wall Street attention, after a rapid-fire stretch of mission milestones, fresh analyst optimism on industry consolidation, and a major U.S. defense procurement update that puts the company alongside the biggest aerospace primes. On Thursday, Rocket Lab shares surged at a double-digit clip after the company successfully executed the STP-S30 mission for the U.S. Space Force—five months ahead of schedule—deploying four experimental “DiskSat” spacecraft into low Earth orbit. The Motley Fool+1 Today, the Space Development Agency (SDA) added to that momentum by
19 December 2025
·····
Hut 8 (HUT) Stock News Today: Analyst Targets Rise After Google-Backed $7 Billion AI Data Center Lease

Hut 8 (HUT) Stock News Today: Analyst Targets Rise After Google-Backed $7 Billion AI Data Center Lease

Dec. 19, 2025 — Hut 8 Corp. (Nasdaq: HUT; TSX: HUT) is back in the market spotlight as investors and analysts digest a headline-grabbing pivot: a long-term, Google-backed AI infrastructure lease that could reshape how Wall Street values the company. Hut 8 shares were trading around $42.55 in Friday trading, up roughly 10% on the session, after swinging between $40.14 and $43.20 earlier in the day. Bitcoin, still a key sentiment driver for many “crypto-adjacent” equities, was hovering near $87,960, down about 1%. The immediate catalyst isn’t Bitcoin mining economics. It’s the market’s attempt to price Hut 8 as something
19 December 2025
······
Applied Digital Corporation Stock (APLD) Today: Macquarie Financing, Hyperscaler Signals, and What Forecasts Say on Dec. 19, 2025

Applied Digital Corporation Stock (APLD) Today: Macquarie Financing, Hyperscaler Signals, and What Forecasts Say on Dec. 19, 2025

December 19, 2025 — Applied Digital Corporation (NASDAQ: APLD) is back in the spotlight at the end of the week as investors weigh a fresh financing update against a louder, market-wide debate: is the AI data-center boom entering its “credit stress” phase, or is this just another volatility pothole on a long runway? By mid-day Friday, APLD shares were trading around $25.68, up roughly 7% on the session, after opening near $24.58. That bounce follows a turbulent stretch where the stock has swung sharply on sentiment around leverage, tenant quality, and the cost of capital—core variables for any company building
19 December 2025
······
Infosys Stock Today: INFY Rises as Accenture Lifts IT Sentiment—Analyst Targets, Q3 Earnings Date, and What Could Move Shares Next

Infosys Stock Today: INFY Rises as Accenture Lifts IT Sentiment—Analyst Targets, Q3 Earnings Date, and What Could Move Shares Next

Infosys Limited (NSE: INFY, BSE: 500209; NYSE: INFY) ended Friday, December 19, 2025 with a modest but telling uptick in India—up 0.81% to ₹1,639.60—as global IT services sentiment improved after Accenture’s latest numbers signaled steadier demand than many investors feared heading into 2026. MarketWatch+1 The move wasn’t just about a single day’s price action. Markets are increasingly treating the next few weeks as a “catalyst corridor” for Infosys stock: a fresh read on enterprise tech budgets, the firm’s ability to convert large deal wins into revenue, and—crucially—whether management tightens or lifts its growth outlook again when it reports its next
19 December 2025
······
Bloom Energy Stock (NYSE: BE) Rebounds on Dec. 19, 2025: Latest News, Analyst Forecasts, and What’s Next for the AI Data-Center Fuel-Cell Play

Bloom Energy Stock (NYSE: BE) Rebounds on Dec. 19, 2025: Latest News, Analyst Forecasts, and What’s Next for the AI Data-Center Fuel-Cell Play

Bloom Energy Corporation stock is back in motion on December 19, 2025, after a week that reminded investors of an eternal market truth: the hottest narratives also come with the sharpest whiplash. As of 14:39 UTC (9:39 a.m. ET), BE stock was trading at $86.06, up $5.85 (+7.29%) on the day, after opening around $81.41 and touching an intraday high of $86.06. That bounce matters because it follows a dramatic string of moves earlier in December—$119.18 on Dec. 5 down to $76.97 on Dec. 17, then a rebound to $80.21 on Dec. 18—a rollercoaster that has turned Bloom Energy stock
19 December 2025
·····
Carnival Corporation & plc Stock (CCL): Record 2025 Results, Dividend Reinstated, and 2026 Outlook — What Changed on Dec. 19, 2025

Carnival Corporation & plc Stock (CCL): Record 2025 Results, Dividend Reinstated, and 2026 Outlook — What Changed on Dec. 19, 2025

Carnival Corporation & plc (NYSE: CCL; NYSE: CUK; LSE: CCL) put a lot of catalysts on the table on December 19, 2025: record full-year performance, a return of the dividend for the first time since the pandemic-era suspension, upbeat 2026 earnings expectations, and a proposal to simplify its dual-listed corporate structure. The market noticed. As of 14:38 UTC on Friday, Dec. 19, shares of Carnival (CCL) traded around $29.34, up roughly $1.00 from the prior close (about +3.5%). Below is a detailed rundown of the news, forecasts, and analyst narratives circulating on 19.12.2025—and what investors are likely to focus on
19 December 2025
·······
CoreWeave Stock (CRWV) Jumps on DOE “Genesis Mission” News and Citi Buy Call: Today’s Forecasts, Catalysts, and Key Risks (Dec. 19, 2025)

CoreWeave Stock (CRWV) Jumps on DOE “Genesis Mission” News and Citi Buy Call: Today’s Forecasts, Catalysts, and Key Risks (Dec. 19, 2025)

Dec. 19, 2025 — CoreWeave, Inc. (Nasdaq: CRWV) is back in the spotlight after a sharp rebound in its share price on Friday, powered by a double dose of momentum: fresh headlines tied to a U.S. government initiative and a renewed (if clearly risk-labeled) vote of confidence from Wall Street. CoreWeave shares were trading around $74.68 in mid-morning U.S. trading (9:39 a.m. ET), up roughly 10% on the day, after closing at about $67.61 on Dec. 18, according to delayed pricing data. FinancialContent In premarket action, a Reuters item carried by TradingView reported the stock was up about 5.9% to
19 December 2025
·····
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion in All‑Cash Deal, Expanding Rare Disease Drug Portfolio

BioMarin to Acquire Amicus Therapeutics for $4.8 Billion in All‑Cash Deal, Expanding Rare Disease Drug Portfolio

BioMarin Pharmaceutical is set to deepen its push into rare metabolic diseases after announcing a definitive agreement to acquire Amicus Therapeutics in an all‑cash transaction valued at approximately $4.8 billion. The deal would add two marketed therapies—Galafold for Fabry disease and Pombiliti + Opfolda for Pompe disease—while also bringing in a Phase 3 kidney-disease program that could widen BioMarin’s late‑stage pipeline. BioMarin Corporate+1 The acquisition is the latest example of a larger biotech company using M&A to secure near‑term revenue and strengthen long‑term growth, particularly in rare disease categories where commercialization requires specialized manufacturing, reimbursement know‑how, and tight engagement with
19 December 2025
····
Banco Bradesco Stock (BBD, BBDC4) in Focus on Dec. 19, 2025: R$3.9B Shareholder Payout, 2026 JCP Calendar, Analyst Targets and Outlook

Banco Bradesco Stock (BBD, BBDC4) in Focus on Dec. 19, 2025: R$3.9B Shareholder Payout, 2026 JCP Calendar, Analyst Targets and Outlook

Banco Bradesco S.A. is closing out 2025 with a shareholder-remuneration headline that’s hard to ignore: the bank’s board approved R$3.9 billion in supplementary “interest on shareholders’ equity” (JCP)—a Brazil-specific payout mechanism that functions a lot like a dividend from an investor’s perspective, but is taxed differently. Investidor10+2Investing.com Brasil+2 For Bradesco stock investors—whether you follow BBDC4 (preferred shares) and BBDC3 (common shares) on Brazil’s B3 exchange or the NYSE-listed ADR (BBD)—today’s news is mainly about cash returns, timing, and what this says about management’s confidence heading into 2026. Investidor10+1 Below is a full, up-to-date wrap of the current news, forecasts, and
19 December 2025
····
1 … 607 608 609 610 611 … 884

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop